NCT02329457View on ClinicalTrials.gov

VZV Vaccine for Hematopoietic Stem Cell Transplantation

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

September 30, 2019

Study Completion Date

October 31, 2019

Conditions
Varicella Zoster Infection
Interventions
BIOLOGICAL

Zostavax

varicella zoster vaccine

BIOLOGICAL

Normal Saline

normal saline placebo vaccine

Trial Locations (1)

Unknown

Ivan Hung, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT02329457 - VZV Vaccine for Hematopoietic Stem Cell Transplantation | Biotech Hunter | Biotech Hunter